Genetic Variants in Matrix Metalloproteinase-9 Gene Modify Metalloproteinase-9 Levels in Black Subjects


Autoria(s): Metzger, Ingrid F.; Luizon, Marcelo R.; Lacchini, Riccardo; Tanus-Santos, Jose Eduardo
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

20/09/2013

20/09/2013

2012

Resumo

Altered matrix metalloproteinases (MMPs) levels are involved in cardiovascular diseases and increased MMP-9 levels enhance the cardiovascular risk in apparently healthy subjects. We investigated the effects of MMP-9 gene polymorphisms and haplotypes on the circulating MMP-9 levels in healthy black subjects and the effects of an MMP-2 polymorphism on the plasma MMP-2 concentrations. We studied 190 healthy subjects, nonsmokers, self-reported as blacks (18-63 years). Genotypes for the MMP-2 C-1306T polymorphism and the MMP-9 C-1562T, 90(CA)(14-24) and Q279R polymorphisms (rs243865, rs3918242, rs2234681, and rs17576, respectively) were determined by TaqMan (R) Allele Discrimination assay and real-time polymerase chain reaction or restriction fragment length polymorphism. Alleles for the 90(CA)(14-24) polymorphism were grouped as low (L) when there were < 21 and high (H) when there were >= 21 CA repeats. The plasma levels of MMP-2 and MMP-9 were determined by gelatin zymography. The software PHASE 2.1 was used to estimate the haplotypes frequencies. Although we found no effects of the MMP-9 C-1562T or the Q279R polymorphisms on MMP-9 levels, higher MMP-9 levels were associated with the HH genotype for the -90(CA)(14-24) polymorphism compared with the HL or LL genotypes. Lower MMP-9 levels were found in carriers of the CRL haplotype (combining the C, R, and L alleles for the MMP-9 polymorphisms) compared with the CRH haplotype. Consistent with this finding, the CRL haplotype was more commonly found in subjects with low MMP-9 levels. The MMP-2 C-1306T polymorphism had no effects on the plasma MMP-2 levels. Our results show that MMP-9 genetic variations modify MMP-9 levels in black subjects and may offer biochemical evidence implicating MMP-9 in the pathogenesis of cardiovascular diseases in blacks.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior

Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior

Identificador

DNA AND CELL BIOLOGY, NEW ROCHELLE, v. 31, n. 4, pp. 504-510, APR, 2012

1044-5498

http://www.producao.usp.br/handle/BDPI/33543

10.1089/dna.2011.1388

http://dx.doi.org/10.1089/dna.2011.1388

Idioma(s)

eng

Publicador

MARY ANN LIEBERT INC

NEW ROCHELLE

Relação

DNA AND CELL BIOLOGY

Direitos

closedAccess

Copyright MARY ANN LIEBERT INC

Palavras-Chave #NITRIC-OXIDE FORMATION #MATRIX METALLOPROTEINASES #CARDIOVASCULAR-DISEASE #VASCULAR DYSFUNCTION #HYPERTENSIVE-RATS #MMP-9 ACTIVITIES #HEALTHY-SUBJECTS #HEART-FAILURE #RISK-FACTORS #PLASMA #BIOCHEMISTRY & MOLECULAR BIOLOGY #CELL BIOLOGY #GENETICS & HEREDITY
Tipo

article

original article

publishedVersion